Laddar...
Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures
BACKGROUND: B-cell depleting drugs show promise for treating multiple sclerosis. OBJECTIVE: We sought predictors of optimal response to rituximab, a B-cell depleting antibody, to help guide therapy selection. METHODS: We performed a post hoc study of 30 relapsing multiple sclerosis patients with bre...
Sparad:
| I publikationen: | Mult Scler J Exp Transl Clin |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433328/ https://ncbi.nlm.nih.gov/pubmed/28607711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217315623800 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|